ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 636859 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 636859; 2) Community: the network communities that were significantly associated with the response to NSC 636859; 3) Molecule: the relationships between components within communities and NSC 636859; 4) MDR: the compounds that were significantly associated with the NSC 636859.

NSC Compound Enrichment Correlation
NSC 731806 Null 0.0252562667234373 0.29957119
NSC 743430 2-{4-[4-(4-{4-[6-(4-methyl piperazino)-1H-benzo[d]imidazole-2-yl]phenoxy}butyl)piperazino]butyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0252562667234373 0.14817648
NSC 745689 3-Cyano-8-chloro-4-imino-2-methyl thio pyrimido[2,1-b]benzothiazole 0.0252562667234373 0.03149791
NSC 749025 Null 0.0252562667234373 0.32720046
NSC 638034 Null 0.027843564133142 0.42357865
NSC 645892 Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- 0.027843564133142 -0.18363779
NSC 648365 Insulin-Methotrexate conjugate 0.027843564133142 0.092768817
NSC 668337 Null 0.027843564133142 0.26247947
NSC 671119 Null 0.027843564133142 0.32288025
NSC 674067 stereoisomer of NSC 674066-O 0.027843564133142 0.38091707
Total:102  Current:66    [First] [Prev] [Next] [Last]